Table 1. Clinical Data of 95 Patients... | American Society of Hematology

Table 1.

Clinical Data of 95 Patients Randomized

N Patients	Randomization Group
	6MPred 2 mg/kg	6MPred 10 mg/kg	P Value
	47 Patients	48 Patients	P Value
Age
Median	26	28	.6
Range	1-55	2-50
Donator's Sex
M	27	32	.3
F	20	16
Recipient's Sex
M	29	24	.2
F	18	24
Disease status
1^ST CR	25	23	.3
>1^STCR	22	25
TBI
Yes	17	18	.2
No	30	30
GvHD Prophylaxis
CS	26	24	.6
CS + MTX	21	24
Interv days BMT-TX
Median	12	12
Range	7-41	6-43	.4
Follow-up days
Median	580	778	.9
Range	12-1417	20-1824

N Patients	Randomization Group
	6MPred 2 mg/kg	6MPred 10 mg/kg	P Value
	47 Patients	48 Patients	P Value
Age
Median	26	28	.6
Range	1-55	2-50
Donator's Sex
M	27	32	.3
F	20	16
Recipient's Sex
M	29	24	.2
F	18	24
Disease status
1^ST CR	25	23	.3
>1^STCR	22	25
TBI
Yes	17	18	.2
No	30	30
GvHD Prophylaxis
CS	26	24	.6
CS + MTX	21	24
Interv days BMT-TX
Median	12	12
Range	7-41	6-43	.4
Follow-up days
Median	580	778	.9
Range	12-1417	20-1824

Abbreviations: 1st CR, first complete remission; Interv BMT-TX, interval in days between transplant and first day of treatment for GvHD.